IRIX News and Press, IRIDEX Corporation

2024-05-17 15:27:03 ET IRIDEX Corporation (IRIX) Q1 2024 Earnings Conference Call May 14, 2024 5:00 PM ET Company Participants Trip Taylor - Investor Relations David Bruce - Chief Executive Officer Fuad Ahmad - Interim Chief Financial Officer Conference Cal...

2024-05-14 16:20:14 ET More on IRIDEX Iridex's Strategic Review Process Should Bear Fruit 'Soon' IRIDEX Corporation (IRIX) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on IRIDEX Historical earnings data for IRIDEX Financial inf...

MOUNTAIN VIEW, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today reported financial results...

AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...

MOUNTAIN VIEW, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today announced the Company...

2024-03-28 19:12:12 ET Summary Iridex Corporation is undergoing a strategic review process to unlock shareholder value. The company is likely to sell its retina business line and potentially parse it out in more than one transaction "soon." The glaucoma business line is highly...

2024-03-26 19:30:17 ET IRIDEX Corporation (IRIX) Q4 2023 Results Conference Call March 26, 2024 05:00 PM ET Company Participants Philip Taylor - IR David Bruce - CEO Fuad Ahmad - Interim CFO Conference Call Participants Tom Stephan - Stifel Pres...

2024-03-26 16:18:45 ET More on IRIDEX Seeking Alpha’s Quant Rating on IRIDEX Historical earnings data for IRIDEX Financial information for IRIDEX Read the full article on Seeking Alpha For further details see: IRIDEX GAAP EPS of -$0.18 miss...

MOUNTAIN VIEW, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today reported financial resul...

Iochpe-Maxion S.A. ADR (IOCJY) is expected to report for quarter end 2023-12-31 The Alkaline Water Company Inc. (WTER) is expected to report for Q3 2024 Clover Leaf Capital Corp. (CLOE) is expected to report for Q4 2023 Silvergate Capital Corporation Class A (SICP) is expected to repo...